vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and Local Bounti Corporation (LOCL). Click either name above to swap in a different company.
Gossamer Bio, Inc. is the larger business by last-quarter revenue ($13.8M vs $12.5M, roughly 1.1× Local Bounti Corporation). Local Bounti Corporation runs the higher net margin — -69.8% vs -342.3%, a 272.5% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 23.7%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
Local Bounti Corporation is a U.S.-based sustainable indoor agriculture firm growing fresh, pesticide-free leafy greens, herbs and produce via advanced hydroponic and vertical farming tech. It serves North American retail and food service partners, focusing on low environmental impact and stable year-round supply.
GOSS vs LOCL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $12.5M |
| Net Profit | $-47.2M | $-8.7M |
| Gross Margin | — | 12.2% |
| Operating Margin | -333.6% | -106.1% |
| Net Margin | -342.3% | -69.8% |
| Revenue YoY | 47.1% | 23.7% |
| Net Profit YoY | -43.0% | 76.0% |
| EPS (diluted) | $-0.21 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $12.5M | ||
| Q3 25 | $13.3M | $12.2M | ||
| Q2 25 | — | $12.1M | ||
| Q1 25 | — | $11.6M | ||
| Q4 24 | — | $10.1M | ||
| Q3 24 | — | $10.2M | ||
| Q2 24 | $95.8M | $9.4M | ||
| Q1 24 | $0 | $8.4M |
| Q4 25 | $-47.2M | $-8.7M | ||
| Q3 25 | $-48.2M | $-26.4M | ||
| Q2 25 | — | $-21.6M | ||
| Q1 25 | — | $-37.7M | ||
| Q4 24 | — | $-36.3M | ||
| Q3 24 | — | $-34.3M | ||
| Q2 24 | $49.2M | $-25.3M | ||
| Q1 24 | $-41.9M | $-24.1M |
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | 11.5% | ||
| Q2 25 | — | 12.2% | ||
| Q1 25 | — | 12.6% | ||
| Q4 24 | — | 5.4% | ||
| Q3 24 | — | 13.8% | ||
| Q2 24 | — | 14.3% | ||
| Q1 24 | — | 9.4% |
| Q4 25 | -333.6% | -106.1% | ||
| Q3 25 | -369.4% | -149.4% | ||
| Q2 25 | — | -127.7% | ||
| Q1 25 | — | -135.6% | ||
| Q4 24 | — | -166.6% | ||
| Q3 24 | — | -176.0% | ||
| Q2 24 | 54.3% | -146.8% | ||
| Q1 24 | — | -122.9% |
| Q4 25 | -342.3% | -69.8% | ||
| Q3 25 | -362.7% | -216.6% | ||
| Q2 25 | — | -178.3% | ||
| Q1 25 | — | -324.6% | ||
| Q4 24 | — | -360.1% | ||
| Q3 24 | — | -335.2% | ||
| Q2 24 | 51.4% | -267.6% | ||
| Q1 24 | — | -286.9% |
| Q4 25 | $-0.21 | $1.52 | ||
| Q3 25 | $-0.21 | $-1.18 | ||
| Q2 25 | — | $-1.63 | ||
| Q1 25 | — | $-4.32 | ||
| Q4 24 | — | $-4.24 | ||
| Q3 24 | — | $-4.01 | ||
| Q2 24 | $0.22 | $-3.00 | ||
| Q1 24 | $-0.19 | $-2.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | $4.2M |
| Total DebtLower is stronger | — | $483.1M |
| Stockholders' EquityBook value | $-122.8M | $-166.2M |
| Total Assets | $172.2M | $410.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | $4.2M | ||
| Q3 25 | $180.2M | $6.2M | ||
| Q2 25 | — | $5.3M | ||
| Q1 25 | — | $18.0M | ||
| Q4 24 | — | $937.0K | ||
| Q3 24 | — | $317.0K | ||
| Q2 24 | $354.5M | $9.7M | ||
| Q1 24 | $244.4M | $8.2M |
| Q4 25 | — | $483.1M | ||
| Q3 25 | — | $484.9M | ||
| Q2 25 | — | $478.3M | ||
| Q1 25 | — | $480.0M | ||
| Q4 24 | — | $436.8M | ||
| Q3 24 | — | $398.4M | ||
| Q2 24 | — | $374.0M | ||
| Q1 24 | — | $329.8M |
| Q4 25 | $-122.8M | $-166.2M | ||
| Q3 25 | $-82.3M | $-158.1M | ||
| Q2 25 | — | $-132.7M | ||
| Q1 25 | — | $-134.5M | ||
| Q4 24 | — | $-100.5M | ||
| Q3 24 | — | $-65.6M | ||
| Q2 24 | $81.5M | $-32.8M | ||
| Q1 24 | $26.7M | $-9.4M |
| Q4 25 | $172.2M | $410.5M | ||
| Q3 25 | $208.8M | $417.8M | ||
| Q2 25 | — | $426.8M | ||
| Q1 25 | — | $447.2M | ||
| Q4 24 | — | $428.0M | ||
| Q3 24 | — | $430.8M | ||
| Q2 24 | $373.4M | $438.1M | ||
| Q1 24 | $259.4M | $413.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $-3.1M |
| Free Cash FlowOCF − Capex | — | $-3.6M |
| FCF MarginFCF / Revenue | — | -29.1% |
| Capex IntensityCapex / Revenue | 0.0% | 3.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-42.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | $-3.1M | ||
| Q3 25 | $-36.2M | $-8.9M | ||
| Q2 25 | — | $-8.7M | ||
| Q1 25 | — | $-9.6M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | $-17.2M | ||
| Q2 24 | $116.3M | $-4.0M | ||
| Q1 24 | $-52.3M | $-7.1M |
| Q4 25 | — | $-3.6M | ||
| Q3 25 | — | $-10.1M | ||
| Q2 25 | — | $-14.6M | ||
| Q1 25 | — | $-14.5M | ||
| Q4 24 | — | $-8.6M | ||
| Q3 24 | — | $-30.0M | ||
| Q2 24 | — | $-28.8M | ||
| Q1 24 | — | $-42.1M |
| Q4 25 | — | -29.1% | ||
| Q3 25 | — | -82.8% | ||
| Q2 25 | — | -121.0% | ||
| Q1 25 | — | -125.1% | ||
| Q4 24 | — | -85.3% | ||
| Q3 24 | — | -293.1% | ||
| Q2 24 | — | -305.4% | ||
| Q1 24 | — | -501.8% |
| Q4 25 | 0.0% | 3.9% | ||
| Q3 25 | 0.0% | 9.7% | ||
| Q2 25 | — | 48.9% | ||
| Q1 25 | — | 42.8% | ||
| Q4 24 | — | 97.6% | ||
| Q3 24 | — | 125.0% | ||
| Q2 24 | 0.0% | 263.0% | ||
| Q1 24 | — | 417.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.36× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
